Read why Fibra-Cel® disks are a promising alternative attachment matrix with a high surface-to- volume ratio and provide a three-dimensional environment that protects cells from damaging shear forces, helping to achieve high cell densities.
Parallel operation of multiple bioreactors and the use of single-use equipment can help reducing development times and ultimately costs.
Single‑use fermenters are becoming an increasingly viable alternative to stainless steel, offering less time is spent on equipment preparation and qualification prior to start-up as well as routine maintenance and requalification of the equipment.
The process design proven for one fermentor system is not always directly transferrable to other system formats without adaptation. Here, we compare the performance of the XDR‑500 MO fermentor with the XDR‑50 MO system.
This study, performed with a prototype system, is designed to confirm the system’s suitability for concentration and diafiltration steps to high final concentrations up to 150 g/L.
This case study shares the work of GE’s Fast Trak Services team to help accelerate development of a process for cGMP production of material for toxicology studies.
A platform that combines drug development expertise and biomanufacturing and integrated services to offer advantages to ADC developers.
Using workflow based software solutions to guide scientists through various processes in low to high throughput screening campaigns.
In this webinar Joaquina Mascarenhas, Ph.D. of Milliporesigma will discuss the following...
Among the primary causes for attrition in early clinical development are safety and pharmacology issues. In the case of biopharmaceuticals, immunogenic and hypersensitivity reactions are perhaps the largest contributors to such early clinical failures
It is estimated that only one out of every 1,000 preclinical candidates reaches the commercial market. The ability to assess the “developability” of a therapeutic candidate in late discovery through clinical phases of development can be an extremely powerful tool to enhance the chance of clinical success. Screening of potential candidates in the discovery process will help to reduce costs, risk (attrition) and overall development time. Being able to assess the manufacturability and safety of the drug candidate, before large investments are made, allows companies to focus on the most promising candidate and maximize R&D spending.
Thanks for your interest in BioSpa™ 8 Automated Incubator. We are excited to share the following product demonstrations with you so you can see how BioSpa links liquid handling, reading and imaging together for unattended workflow automation. We’ll provide examples of typical assay workflows to help you understand exactly how BioSpa can help you take control of your cell assays.
The Mobius® Power MIX 1000 and 2000 combine high performance mixing technology with design features that make them easy to use. The impeller design and motor are based on our magnetically coupled NovAseptic® mixing technology, a proven mixing technology in stainless steel tanks. The system efficiently mixes the most challenging buffers, media and biopharmaceutical ingredients.
For over 60 years, New Brunswick Shakers have been synonymous with quality construction and durability. They have been used in more labs the world over than any other shaker and our top-of-the line Innova models continue to be the market leaders.
Since their introduction over twenty years ago, Galaxy CO2 Incubators have become a mainstay in cell culture laboratories all over the world. They set the standard for advanced features and are designed to meet real world needs. They were first to use a fan-less design, direct heating technology and a seamless chamber. Time and again, features like these have helped to improve laboratory processes and cell culture results.